Literature DB >> 17291892

Cholera: assessing the risk to travellers and identifying methods of protection.

Robert Steffen1, Jacques Acar, Eric Walker, Jane Zuckerman.   

Abstract

This review is based on the findings of a consultation meeting involving consultants in travel medicine and focusing on the risks of cholera to the traveller. Cholera is a severe diarrhoeal disease transmitted via the faeco-oral route and commonly associated with poor sanitation. Between the years of 1995 and 2001, the WHO reported 1829 cases of cholera in developed countries, the majority of which were imported. However, it is believed that this figure reflects less than 10% of the true incidence of cholera due to milder cases being unrecognised, as well as significant underreporting. Travellers to epidemic countries may be at increased risk of contracting cholera if they ingest contaminated food or water. It has been estimated that there are 0.2 cases of cholera per 100,000 European and North American travellers, though there is some evidence that this rate is higher. Oral vaccines are a necessary and welcome advance as, in addition to preventing illness, they can minimise the possibility of transmission of cholera to disease-free regions. The morbidity from cholera can range from asymptomatic or oligosymptomatic infection to disruption of holiday and business plans, or even severe toxicity and dehydration. If untreated, severe illnesses can be fatal, although fatalities have not been reported among travellers for many years.

Entities:  

Year:  2003        PMID: 17291892     DOI: 10.1016/S1477-8939(03)00062-0

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  5 in total

1.  Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.

Authors:  Wilbur H Chen; Richard N Greenberg; Marcela F Pasetti; Sofie Livio; Michael Lock; Marc Gurwith; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

2.  Oral cholera vaccine for traveler's diarrhea prophylaxis.

Authors:  Tony Nickonchuk; Adrienne J Lindblad; Michael R Kolber
Journal:  Can Fam Physician       Date:  2014-05       Impact factor: 3.275

3.  Prevalence of cholera in pediatric patients with acute dehydrating diarrhea.

Authors:  Vijesh S Kuttiat; Rakesh Lodha; Bimal Das; Utkarsh Kohli
Journal:  Indian J Pediatr       Date:  2010-02-05       Impact factor: 1.967

Review 4.  Focus on acute diarrhoeal disease.

Authors:  Fabio Baldi; Maria Antonia Bianco; Gerardo Nardone; Alberto Pilotto; Emanuela Zamparo
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

5.  Cholera in travellers: a systematic review.

Authors:  Bradley A Connor; Richard Dawood; Mark S Riddle; Davidson H Hamer
Journal:  J Travel Med       Date:  2019-12-23       Impact factor: 8.490

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.